Published in Rheumatol Int on May 21, 2011
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol (2005) 5.99
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis (2001) 3.68
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05
Measurement of renal function in chronic renal disease. Kidney Int (1990) 2.72
Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism (2006) 2.14
Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens (2001) 1.91
Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm (1983) 1.61
Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens (2006) 1.53
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft Gault equations. Lupus (2007) 1.04
Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. Lupus (2007) 1.03
Measuring filtration function in clinical practice. Curr Opin Nephrol Hypertens (2006) 0.89
A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis. Lupus (2008) 0.85
Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis. Nephrology (Carlton) (2008) 0.80
[Cystatin C: yes, but...]. Nefrologia (2006) 0.78
Estimation of glomerular filtration rate in patients with systemic lupus erythematosus. Lupus (2006) 0.78
Management of cardiovascular risk factors in patients with systemic lupus erythematosus. Acta Reumatol Port (2008) 0.77
Estimation of glomerular filtration rate based on the modification of diet in renal disease equation in patients with chronic renal failure. Kidney Blood Press Res (2005) 0.77
Systemic diseases with renal manifestations. Prim Care (2008) 0.77
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med (2006) 5.03
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet (2008) 3.00
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial. Ann Rheum Dis (2011) 2.13
Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun (2006) 1.83
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum (2008) 1.73
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.59
Invasive fungal infections in patients with systemic lupus erythematosus. J Rheumatol (2012) 1.44
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther (2006) 1.42
[Interstitial lung disease (ILD) in rheumatoid arthritis (RA)]. Rev Invest Clin (2014) 1.39
Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol (2009) 1.25
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum (2010) 1.24
Neuropsychiatric manifestations of systemic lupus erythematosus. J Rheumatol (2013) 1.09
CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol (2011) 1.02
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study. Ann Rheum Dis (2012) 0.96
Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (2012) 0.88
Rheumatoid arthritis and the role of oral bacteria. J Oral Microbiol (2010) 0.87
IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's disease. Reumatol Clin (2013) 0.82
Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol (2013) 0.81
Treating severe systemic lupus erythematosus with rituximab. An open study. Reumatol Clin (2009) 0.81
A male patient with cavitary pulmonary disease. Reumatol Clin (2012) 0.79
[Recommendations for the medical treatment of rheumatoid arthritis]. Rev Invest Clin (2006) 0.79
[Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology]. Gac Med Mex (2009) 0.78
[Calciphylaxis, renal failure and gout. A patient with hyperuricemia as a risk factor for death]. Rev Med Inst Mex Seguro Soc (2013) 0.78
[Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)]. Rev Invest Clin (2009) 0.78
Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers. J Pharm Pharmacol (2014) 0.77
Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus. J Clin Immunol (2010) 0.77
Serum cystatin C as a marker of renal function in patients with systemic lupus erythematosus. Reumatol Clin (2012) 0.77
Hyperglycemia and methylprednisolone: comment on the article by den Uyl et al. Arthritis Rheum (2012) 0.76
Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries? J Rheumatol (2010) 0.76
Estimating glomerular filtration rate. N Engl J Med (2012) 0.75
[Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: experience with six pediatric patients. Potential efficacy of methotrexate]. Rev Neurol (2013) 0.75
Prevalence of chronic rheumatic diseases in Mexico. J Rheumatol (2011) 0.75
Severe and unresponsive HIV-associated alopecia areata successfully treated with thalidomide. Acta Derm Venereol (2005) 0.75
Concomitant therapy with statins and immunosuppressive agents in childhood primary angiitis of the central nervous system: comment on the article by Cellucci et al. Arthritis Rheum (2012) 0.75
Medical ethics, research and the pharmaceutical industry. Reumatol Clin (2012) 0.75
Neuropsychiatric manifestations in systemic lupus erythematosus: physiopathogenic and therapeutic basis. Reumatol Clin (2013) 0.75
Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman. Rheumatology (Oxford) (2012) 0.75
Laboratory biomarkers for guiding therapy with methotrexate in rheumatoid arthritis. Curr Pharm Des (2015) 0.75
Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success? Reumatol Clin (2013) 0.75
CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus. Nefrologia (2013) 0.75
Economic impact of estimating renal function in patients with systemic lupus erythematosus. Nefrologia (2012) 0.75
[Experience in kidney transplantation from 1999 to 2011 at the Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí]. Rev Invest Clin (2011) 0.75